Corona Remedies has acquired Wokadine brand from Dr. Reddy’s Laboratories in India. The acquisition, effective March 30, marks the company’s entry into the ₹648 crore Povidone Iodine market in India. Wokadine is ranked number two in the market and the brand holds strong potential for accelerated growth under its stewardship, Corona said on Monday. Wokadine comprises 14 SKUs having different applications. The company said the acquisition will be fully funded through internal accruals and cash. For Corona Remedies, which continuously assesses both organic and inorganic growth opportunities, the latest acquisition will enhance and strengthen existing product portfolio, V-P Corporate Strategy and Business Development Tejas Kothari said in a release. Published – March 31, 2026 09:53 pm IST Share this: Click to share on WhatsApp (Opens in new window) WhatsApp Click to share on Facebook (Opens in new window) Facebook Click to share on Threads (Opens in new window) Threads Click to share on X (Opens in new window) X Click to share on Telegram (Opens in new window) Telegram Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Pinterest (Opens in new window) Pinterest Click to email a link to a friend (Opens in new window) Email More Click to print (Opens in new window) Print Click to share on Reddit (Opens in new window) Reddit Click to share on Tumblr (Opens in new window) Tumblr Click to share on Pocket (Opens in new window) Pocket Click to share on Mastodon (Opens in new window) Mastodon Click to share on Nextdoor (Opens in new window) Nextdoor Click to share on Bluesky (Opens in new window) Bluesky Like this:Like Loading... Post navigation 44 Maoists surrender in Bastar; Chhattisgarh now Maoists-free, asserts CM 15 sentenced to life imprisonment in murder case